TABLE 3.

Interaction of MicroCog Score by Treatment Condition on Percentage of Study Weeks and Percentage of Tested Study Weeks with Continuous Opioid Abstinence

	Percentage of Study Weeks with Continuous Opioid Abstinence			Percentage of Tested Study Weeks with Continuous Opioid Abstinence
MicroCog Index	Estimate	SE	t	Estimate	SE	t
Attention/Mental Control	0.023	0.003	7.05****	0.0217	0.003	6.66****
Attention/Mental Control by Treatment Group	−0.025	0.004	−6.01****	−0.021	0.004	−4.95****
Reasoning	0.011	0.003	3.60***	0.009	0.003	3.09***
Reasoning by Treatment Group	−0.005	0.004	−1.29	0.000	0.004	0.06
Memory	0.011	0.003	3.53***	−0.010	0.003	3.26**
Memory by Treatment Group	−0.011	0.004	−2.73**	−0.010	0.004	−2.28*
Spatial Processing	−0.002	0.003	−0.46	−0.000	0.003	−0.09
Spatial Processing by Treatment Group	0.008	0.005	1.64	0.005	0.005	1.16
Reaction Time	0.014	0.003	4.34****	0.014	0.003	4.33****
Reaction Time by Treatment Group	0.000	0.004	0.01	0.001	0.004	0.25
Information Processing Speed	0.005	0.003	2.02*	0.005	0.003	1.86
Information Processing Speed by Treatment Group	0.001	0.003	0.41	0.003	0.003	0.95
Information Processing Accuracy	0.027	0.004	6.80****	0.026	0.004	6.49****
Information Processing Accuracy by Treatment Group	−0.032	0.005	−6.88****	−0.030	0.005	−6.23****
General Cognitive Functioning	0.016	0.003	5.10****	0.016	0.003	4.75****
General Cognitive Functioning by Treatment Group	−0.016	0.004	−3.71***	−0.012	0.004	−2.77***
General Cognitive Processing	0.012	0.004	2.96**	0.0124	0.004	2.95**
General Cognitive Processing by Treatment Group	−0.008	0.005	−1.62	−0.004	0.005	−0.78

^****p < .0001,

^***p<0.001,

^**p <.01,

^*p <.05